Antitargets and drug safety /

With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals with novel technologies and includes the utility of a...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Urbán, László, Patel, Vinod F., Vaz, Roy J.
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Weinheim : Wiley-VCH, 2015.
Σειρά:Methods and principles in medicinal chemistry ; v. 66.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 05672nam a2200697 4500
001 ocn904518353
003 OCoLC
005 20170124070543.2
006 m o d
007 cr cnu---unuuu
008 150307s2015 gw ob 001 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCO  |d RECBK  |d N$T  |d YDXCP  |d IDEBK  |d CDX  |d DG1  |d E7B  |d OCLCF  |d COO  |d DEBBG  |d OCLCQ  |d OHI  |d GrThAP 
019 |a 909907512  |a 953987850  |a 960203676  |a 961625844  |a 962626284 
020 |a 9783527673643  |q (electronic bk.) 
020 |a 3527673644  |q (electronic bk.) 
020 |a 9783527673674  |q (electronic bk.) 
020 |a 3527673679  |q (electronic bk.) 
020 |z 9783527673667 
020 |z 3527673660 
020 |z 9783527335114 
020 |z 3527335110 
029 1 |a CHDSB  |b 006359936 
029 1 |a CHVBK  |b 332136523 
029 1 |a DEBBG  |b BV042792550 
029 1 |a DEBBG  |b BV043397595 
035 |a (OCoLC)904518353  |z (OCoLC)909907512  |z (OCoLC)953987850  |z (OCoLC)960203676  |z (OCoLC)961625844  |z (OCoLC)962626284 
050 4 |a RS420 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 4 |a 615.19  |2 23 
049 |a MAIN 
245 0 0 |a Antitargets and drug safety /  |c edited by Laszlo Urban, Vinod F. Patel and Roy J. Vaz. 
264 1 |a Weinheim :  |b Wiley-VCH,  |c 2015. 
300 |a 1 online resource (1266 pages). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Methods and principles in medicinal chemistry ;  |v v. 66 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a General Concept for Target-based Safety Assessment. Side Effects of Marketed Drugs: The Utility and Pitfalls of Pharmacovigilance / Steven Whitebread, Mateusz Maciejewski, Alexander Fekete, Eugen Lounkine, László Urbán -- Prediction of Drug Side Effects / Michael J Keiser -- Translational Value of Preclinical Safety Assessment: System Organ Class (SOC) Representation of Off-Targets / Mateusz Maciejewski, Eugen Lounkine, Andreas Hartmann, Steven Whitebread, László Urbán -- Pathological Conditions Associated with the Disturbance of the 5-HT System / Daniel Hoyer -- Hepatic Side Effects. Drug-Induced Liver Injury: Clinical and Diagnostic Aspects / John R Senior -- Mechanistic Safety Biomarkers for Drug-Induced Liver Injury / Daniel J Antoine -- Models for the Prediction of Drug-Induced Liver Injury in Lead Discovery / Frederic Moulin, Oliver Flint -- Transporters in the Liver / Bruno Stieger, Gerd A Kullak-Ublick -- Mechanistic Modeling of Drug-Induced Liver Injury (DILI) / Kyunghee Yang, Jeffrey L Woodhead, Lisl K Shoda, Yuching Yang, Paul B Watkins, Kim LR Brouwer, Brett A Howell, Scott Q Siler -- Cardiovascular Side Effects. Functional Cardiac Safety Evaluation of Novel Therapeutics / Jean-Pierre Valentin, Brian Guth, Robert L Hamlin, Pierre Lainée, Dusty Sarazan, Matt Skinner -- Safety Aspects of the Ca1.2 Channel / Berengere Dumotier, Martin Traebert -- Cardiac Sodium Current (Na1.5) / Gary Gintant -- Circulating Biomarkers for Drug-Induced Cardiotoxicity: Reverse Translation from Patients to Nonclinical Species / Gül Erdemli, Haisong Ju, Sarita Pereira -- The Mechanistic Basis of hERG Blockade and the Proarrhythmic Effects Thereof / Robert A Pearlstein, K Andrew MacCannell, Qi-Ying Hu, Ramy Farid, José S Duca -- Kinase Antitargets. Introduction to Kinase Antitargets / Mark C Munson -- Clinical and Nonclinical Adverse Effects of Kinase Inhibitors / Douglas A Keller, Richard J Brennan, Karen L Leach -- Cardiac Side Effects Associated with Kinase Proteins and Their Signaling Pathways / Roy J Vaz, Vinod F Patel -- Case Studies: Selective Inhibitors of Protein Kinases : Exploiting Demure Features / Ellen R Laird -- Examples of Clinical Translation. Torcetrapib and Dalcetrapib Safety: Relevance of Preclinical and Models / Eric J Niesor, Andrea Greiter-Wilke, Lutz Müller -- Targets Associated with Drug-Related Suicidal Ideation and Behavior / Andreas Hartmann, Steven Whitebread, Jacques Hamon, Alexander Fekete, Christian Trendelenburg, Patrick Y Müller, László Urbán. 
520 |a With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals with novel technologies and includes the utility of adverse event reports to drug discovery, the translational aspects of preclinical safety findings, broader computational prediction of drug side-effects, and a description of the serotonergic system. The main part of the book looks at some of the most common antitarget-mediated side effects, focusing. 
650 0 |a Drug development. 
650 0 |a Drugs  |x Design. 
650 0 |a Drugs  |x Side effects. 
650 0 |a Drug interactions. 
650 4 |a Drug development. 
650 4 |a Drugs  |x Design. 
650 4 |a Medicine. 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Drug development.  |2 fast  |0 (OCoLC)fst00898670 
650 7 |a Drug interactions.  |2 fast  |0 (OCoLC)fst00898681 
650 7 |a Drugs  |x Design.  |2 fast  |0 (OCoLC)fst00898790 
650 7 |a Drugs  |x Side effects.  |2 fast  |0 (OCoLC)fst00898912 
655 4 |a Electronic books. 
700 1 |a Urbán, László. 
700 1 |a Patel, Vinod F. 
700 1 |a Vaz, Roy J. 
776 0 8 |i Print version:  |a Urban, Laszlo.  |t Antitargets and Drug Safety.  |d Hoboken : Wiley, ©2015  |z 9783527335114 
830 0 |a Methods and principles in medicinal chemistry ;  |v v. 66. 
856 4 0 |u https://doi.org/10.1002/9783527673643  |z Full Text via HEAL-Link 
994 |a 92  |b DG1